T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in OncologySteven M. Horwitz, Hema Sundar, Stephen M. Ansell et al.|Journal of the National Comprehensive Cancer Network|2022Cited by 172
NCCN Guidelines Insights: Primary Cutaneous Lymphomas, Version 2.2020Neha Mehta–Shah, Youn H. Kim, Sarah McCue Horwitz et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 121
NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018Steven M. Horwitz, Hema Sundar, Stephen M. Ansell et al.|Journal of the National Comprehensive Cancer Network|2018Cited by 79
NCCN Guidelines Insights: T-Cell Lymphomas, Version 1.2021Steven M. Horwitz, Hema Sundar, Stephen M. Ansell et al.|Journal of the National Comprehensive Cancer Network|2020Cited by 62
Long‐term outcomes, secondary malignancies and stem cell collection following bendamustine in patients with previously treated non‐Hodgkin lymphomaPeter Martin, John P. Leonard, Bernard Lemieux et al.|British Journal of Haematology|2017Cited by 33